Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
10.1016/j.foodchem.2018.10.010 Food Chem
Jain P, Garg RK, Kapoor A
But when her team analyzed the FDA Adverse Event Reporting System (FAERS) a post-marketing surveillance database where patients, caregivers and clinicians voluntarily report potential side effects they found that some people taking GLP-1 receptor agonists reported parosmia, a smell distortion disorder in which familiar scents suddenly smell "wrong," and often unpleasant
Research compounds
Our lead clinical programs drug candidate, VK2735, is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity
doi: 10.3389/fphar.2021.701564 89 SunLWangHWangZHeSChenSLiaoDet al
US$ 29.76
US$ 21.04
US$ 28.98
